End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 SEK | -5.48% | -.--% | -21.85% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Capitalization 1 | 316.2 | 494.2 | 377.3 | 273.8 | 92.97 |
Enterprise Value (EV) 1 | 310.7 | 470.4 | 290.5 | 203 | 22.56 |
P/E ratio | -33.1 x | -37.6 x | -23.4 x | -9.8 x | -1.36 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 92.2 x | 111 x | 54.6 x | 46.8 x | 12.1 x |
EV / Revenue | 90.6 x | 105 x | 42.1 x | 34.7 x | 2.94 x |
EV / EBITDA | - | - | - | - | -509,046 x |
EV / FCF | -23.9 x | -33.2 x | -13.9 x | -7.05 x | -1.26 x |
FCF Yield | -4.19% | -3.01% | -7.17% | -14.2% | -79.1% |
Price to Book | 8.13 x | 7.79 x | 2.72 x | 2.01 x | 0.75 x |
Nbr of stocks (in thousands) | 5,314 | 6,377 | 8,115 | 9,283 | 14,107 |
Reference price 2 | 59.50 | 77.50 | 46.50 | 29.50 | 6.590 |
Announcement Date | 5/2/19 | 4/23/20 | 5/6/21 | 4/21/22 | 4/20/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 2.239 | 3.43 | 4.468 | 6.907 | 5.857 | 7.679 |
EBITDA | - | - | - | - | - | -44.32 |
EBIT 1 | -5.694 | -9.573 | -12.55 | -13.55 | -24.97 | -45.37 |
Operating Margin | -254.31% | -279.07% | -280.84% | -196.15% | -426.39% | -590.91% |
Earnings before Tax (EBT) 1 | -5.727 | -9.588 | -12.57 | -13.56 | -24.74 | -46.8 |
Net income 1 | -5.727 | -9.588 | -12.57 | -13.56 | -24.74 | -46.8 |
Net margin | -255.78% | -279.5% | -281.23% | -196.34% | -422.5% | -609.52% |
EPS 2 | -4.174 | -1.800 | -2.060 | -1.990 | -3.010 | -4.830 |
Free Cash Flow 1 | -6.005 | -13.01 | -14.17 | -20.83 | -28.78 | -17.85 |
FCF margin | -268.2% | -379.25% | -317.16% | -301.54% | -491.37% | -232.49% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 1/29/18 | 5/2/19 | 4/23/20 | 5/6/21 | 4/21/22 | 4/20/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 3.81 | 5.53 | 23.8 | 86.9 | 70.8 | 70.4 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -6.01 | -13 | -14.2 | -20.8 | -28.8 | -17.9 |
ROE (net income / shareholders' equity) | -21.4% | -27.8% | -24.6% | -13.4% | -18% | -35.9% |
ROA (Net income/ Total Assets) | -11.9% | -15.8% | -14.2% | -7.97% | -10.9% | -19.5% |
Assets 1 | 48.01 | 60.78 | 88.64 | 170.2 | 228 | 240.1 |
Book Value Per Share 2 | 5.960 | 7.310 | 9.950 | 17.10 | 14.70 | 8.790 |
Cash Flow per Share 2 | 0.9200 | 1.200 | 3.860 | 10.80 | 3.380 | 3.410 |
Capex 1 | 3.62 | 1.01 | - | 1.51 | 2.57 | 4.9 |
Capex / Sales | 161.72% | 29.38% | - | 21.89% | 43.93% | 63.84% |
Announcement Date | 1/29/18 | 5/2/19 | 4/23/20 | 5/6/21 | 4/21/22 | 4/20/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-21.85% | 8.35M | |
+25.98% | 360B | |
+18.14% | 121B | |
+10.67% | 19.99B | |
+5.56% | 18.83B | |
+35.96% | 9.77B | |
+24.11% | 9.34B | |
-7.97% | 7.54B | |
-23.57% | 6.08B | |
+36.78% | 5.4B |
- Stock Market
- Equities
- SMOL Stock
- Financials Smoltek Nanotech Holding AB